Cover Image

Comparing the Effects of Epley Maneuver and Cinnarizine on Benign Positional Paroxysmal Vertigo; A Randomized Clinical Trial

Masoumeh Saeedi, Mohammad Hossein Khosravi, Mohammad Ehsan Bayatpoor

Background: The fastest and safest treatment method of BPPV is repositioning maneuvers. In Iran, this methods are not widely used, and many physicians use medical therapy, despite their side effects, for management of BPPV. Materials and Methods: In this randomized clinical trial patients with BPPV were randomly allocated to Epley repositioning maneuver or Cinnarizine (25mg every 8 hours) for two weeks. The patients were evaluated for symptoms using visual analogue scale (VAS) scoring system before intervention, first and second weeks after intervention. In the second and third visitd the results of hallpike test was recorded for both groups. Results: 43 patients with a mean age of 46.88±11.08 years in two Epley and Cinnarizine group underwent analysis. The mean VAS score for improvement of symptoms after intervention was 1.66±1.06 in Epley and 1.50±0.91 in Cinnarizine group (P=0.57). Conclusion: we found that there is no significant difference between Epley maneuver and Cinnarizine for treatment and controlling symptoms of BPPV. [GMJ.2019;8:e866]

Benign Paroxysmal Positional Vertigo; Cinnarizine; Epley Maneuver; Vertigo

Von Brevern M, Radtke A, Lezius F, Feldmann M, Ziese T, Lempert T, et al. Epidemiology of benign paroxysmal positional vertigo: a population based study. J. Neurol. Neurosurg. Psychiatry. 2007;78(7):710-5.

PMid:17135456 PMCid:PMC2117684

Epley J, Arenber I. Benign paroxysmal vertigo (canalithiasis): diagnosis and non-surgical treatment. Dizziness and balance disorders. 1993:545-59.

Hall S, Ruby R, McClure J. The mechanics of benign paroxysmal vertigo. J otolaryngol. 1979;8(2):151-8.


Hornibrook J. Benign paroxysmal positional vertigo (BPPV): history, pathophysiology, office treatment and future directions. Int J otolaryngol. 2011;2011:13

PMid:21808648 PMCid:PMC3144715

Parnes LS, Mcclure JA. Free‐floating endolymph particles: a new operative finding during posterior semicircular canal occlusion. Laryngoscope. 1992;102(9):988-92.

Strain G, Myers L, Reece W. Hearing and equilibrium. Dukes' physiology of domestic animals. 2004(Ed. 12):852-64.

Claes J. A review of medical treatment for Meniere's disease. Acta Otolaryngol. 2000;120(544):34-9.

Cohen HS, Kimball KT. Increased independence and decreased vertigo after vestibular rehabilitation.Otolaryngol Head Neck Surg . 2003;128(1):60-70.


Hain TC, Uddin M. Pharmacological treatment of vertigo. CNS drugs. 2003;17(2):85-100.

Mira E, Guidetti G, Ghilardi P, Fattori B, Malannino N, Maiolino L, et al. Betahistine dihydrochloride in the treatment of peripheral vestibular vertigo.Eur Arch Otorhinolaryngol. 2003;260(2):73-7. PMid:12582782

Oosterveld W, editor Cinnarizine in the vertiginous syndrome. Cinnarizine and the vertiginous syndrome. International Congress and Symposium Series; 1979.

Arab SF, Düwel P, Jüngling E, Westhofen M, Lückhoff A. Inhibition of voltage-gated calcium currents in type II vestibular hair cells by cinnarizine. Naunyn Schmiedebergs Arch Pharmacol. 2004;369(6):570-5.


Furman JM, Cass SP. Benign paroxysmal positional vertigo. N Engl J Med. 1999;341(21):1590-6.


Nilles R. A direct effect of calcium antagonists in the inner ear: Blockage of abnormal calcium increase in outer hair cells of the guinea pig. HNO. 1995;43(12):716-23.


Cohen HS, Kimball KT. Treatment variations on the Epley maneuver for benign paroxysmal positional vertigo. Am J Otolaryngol. 2004;25(1):33-7.

Steenerson RL, Cronin GW, Marbach PM. Effectiveness of treatment techniques in 923 cases of benign paroxysmal positional vertigo. Laryngoscope. 2005;115(2):226-31.


Helminski JO, Zee DS, Janssen I, Hain TC. Effectiveness of particle repositioning maneuvers in the treatment of benign paroxysmal positional vertigo: a systematic review. Phys Ther. 2010;90(5):663-78.


Sundararajan I, Rangachari V, Sumathi V, Kumar K. Epley's manoeuvre versus Epley's manoeuvre plus labyrinthine sedative as management of benign paroxysmal positional vertigo: prospective, randomised study. J Laryngol Otol. 2011;125(06):572-5.


Guneri EA, Kustutan O. The effects of betahistine in addition to epley maneuver in posterior canal benign paroxysmal positional vertigo. Otolaryngol Head Neck Surg. 2012;146(1):104-8.


Foster CA, Ponnapan A, Zaccaro K, Strong D. A comparison of two home exercises for benign positional vertigo: Half somersault versus Epley Maneuver. Audiol Neurotol Extra. 2012;2(1):16-23.

Maslovara S, Soldo SB, Puksec M, Balaban B, Penavic IP. Benign paroxysmal positional vertigo (BPPV): influence of pharmacotherapy and rehabilitation therapy on patients' recovery rate and life quality. NeuroRehabilitation. 2012;31(4):435-41.


Kim JH, Jung EJ, Song CE, Song MH, Park KC, Ko KM, et al. Risk factors for treatment failure in benign paroxysmal positional vertigo. Korean J Otorhinolaryngol-Head Neck Surg.2013;56(2):74-8.

Sato G, Sekine K, Matsuda K, Takeda N. Risk factors for poor outcome of a single Epley maneuver and residual positional vertigo in patients with benign paroxysmal positional vertigo. Acta Otolaryngol. 2013;133(11):1124-7.


Oh S-Y, Kim J-S, Choi K-D, Park J-Y, Jeong S-H, Lee S-H, et al. Switch to Semont maneuver is no better than repetition of Epley maneuver in treating refractory BPPV. J. Neurol. 2017;264(9):1892-8.


Kaur J, Shamanna K. Management of Benign Paroxysmal Positional Vertigo: A Comparative Study between Epleys Manouvre and Betahistine.Int. Tinnitus J.2017;21(1):29-33.



  • There are currently no refbacks.